Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.92 USD | -0.17% | -12.50% | -30.25% |
05-16 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
04-08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.25% | 364M | |
+62.60% | 62.59B | |
-2.41% | 41.18B | |
+44.59% | 40.29B | |
-8.29% | 27.9B | |
+12.49% | 26.21B | |
-21.86% | 19.09B | |
+5.02% | 13.08B | |
+24.82% | 12.26B | |
+28.19% | 12.05B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Transcript : Replimune Group, Inc. - Shareholder/Analyst Call